tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Precision BioSciences Inc

DTIL
Add to Watchlist
6.990USD
-0.010-0.14%
Close 07-31 16:00（ET）Quotes delayed by 15 min
180.36MMarket Cap
LossP/E TTM

Precision BioSciences Inc

6.990
-0.010-0.14%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

DTIL Financials

See Precision BioSciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Precision BioSciences Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
--/-0.79
Revenue / Forecast
--/1.13M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
34.26M
-50.12%
EPS(YoY)
-3.56
-439.88%
Analyst Rating
STRONG BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
66.18%-0.75
147.52%1.05
18.27%-1.84
-145.29%-2.13
-230.42%-2.21
45.43%-2.22
-7.10%-2.25
250.35%4.70
125.12%1.70
47.17%-4.06
---2.10
---3.13
---6.75
---7.69
----
----
----
----
----
----
Revenue
37272.41%10.84M
5261.13%34.20M
-97.74%13.00K
-99.96%18.00K
-99.84%29.00K
-90.93%638.00K
-95.61%576.00K
152.15%49.90M
100.27%17.58M
-33.59%7.04M
78.19%13.12M
418.04%19.79M
164.70%8.78M
67.19%10.60M
-69.37%7.36M
-94.45%3.82M
-79.71%3.32M
-28.34%6.34M
226.44%24.04M
6282.65%68.81M
Net Profit
10.33%-18.44M
213.46%20.13M
-32.55%-21.77M
-171.82%-23.52M
-339.46%-20.57M
-8.94%-17.75M
-103.30%-16.43M
375.41%32.75M
134.27%8.59M
42.82%-16.29M
66.26%-8.08M
61.69%-11.89M
11.03%-25.06M
-27.81%-28.49M
-112.31%-23.95M
-243.31%-31.04M
-50.72%-28.17M
4.96%-22.29M
56.65%-11.28M
166.22%21.66M
Net Margin
99.76%-170.15%
102.02%56.27%
-5773.16%-167476.92%
-199190.21%-130666.67%
-145296.58%-70913.79%
-1357.13%-2781.35%
-2989.39%-2851.56%
528.22%65.63%
130.74%48.84%
-4.13%-190.88%
---92.30%
---15.33%
---158.88%
---183.31%
----
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
Debt to assets ratio
-13.22%15.58%
-11.35%14.51%
64.60%23.93%
51.26%20.52%
47.68%17.95%
16.68%16.37%
6.82%14.54%
10.46%13.57%
11.64%12.16%
50.33%14.03%
--13.61%
--12.28%
--10.89%
--9.33%
----
----
----
----
----
----
Income Statement
Revenue
37272.41%10.84M
5261.13%34.20M
-97.74%13.00K
-99.96%18.00K
-99.84%29.00K
-90.93%638.00K
-95.61%576.00K
152.15%49.90M
100.27%17.58M
-33.59%7.04M
78.19%13.12M
418.04%19.79M
164.70%8.78M
67.19%10.60M
-69.37%7.36M
-94.45%3.82M
-79.71%3.32M
-28.34%6.34M
226.44%24.04M
6282.65%68.81M
Operating profit
58.96%-9.07M
150.34%12.51M
2.86%-20.67M
-190.60%-21.88M
-428.11%-22.11M
-66.86%-24.85M
-72.09%-21.27M
871.68%24.15M
68.65%-4.19M
-22.97%-14.89M
15.76%-12.36M
89.41%-3.13M
51.15%-13.35M
60.59%-12.11M
-27.15%-14.68M
-236.62%-29.55M
-45.85%-27.34M
-30.85%-30.72M
55.68%-11.54M
165.94%21.63M
Net Profit
10.33%-18.44M
213.46%20.13M
-32.55%-21.77M
-171.82%-23.52M
-339.46%-20.57M
-8.94%-17.75M
-103.30%-16.43M
375.41%32.75M
134.27%8.59M
42.82%-16.29M
66.26%-8.08M
61.69%-11.89M
11.03%-25.06M
-27.81%-28.49M
-112.31%-23.95M
-243.31%-31.04M
-50.72%-28.17M
4.96%-22.29M
56.65%-11.28M
166.22%21.66M
Balance Sheet
Current assets
32.39%108.69M
25.00%118.74M
-53.22%51.70M
-51.22%70.26M
-48.95%82.10M
-30.34%94.99M
-24.22%110.52M
-2.59%144.03M
-4.85%160.83M
-31.51%136.36M
-35.28%145.85M
-40.30%147.86M
26.08%169.02M
23.09%199.10M
23.12%225.37M
31.54%247.69M
-38.83%134.05M
53.23%161.75M
49.35%183.05M
37.06%188.30M
Total current liabilities
-37.42%7.75M
-40.50%8.91M
25.15%15.00M
-58.83%13.57M
-62.83%12.39M
-70.03%14.98M
-76.33%11.98M
-41.56%32.96M
-28.85%33.34M
-16.22%49.99M
-17.22%50.62M
4.59%56.40M
60.99%46.86M
65.83%59.66M
67.64%61.15M
48.75%53.92M
-54.38%29.11M
-15.99%35.98M
-13.12%36.48M
5.65%36.25M
Total assets
15.66%143.89M
13.22%154.42M
-38.99%93.51M
-34.30%108.93M
-32.66%124.41M
-14.64%136.39M
-6.75%153.26M
-8.75%165.80M
-9.66%184.74M
-32.91%159.78M
-39.52%164.34M
-38.86%181.70M
12.77%204.50M
12.61%238.17M
19.60%271.73M
29.14%297.16M
-30.87%181.35M
40.85%211.50M
34.69%227.20M
24.93%230.11M
Total liabilities
-9.70%67.79M
-22.29%62.17M
-13.03%76.88M
-17.80%74.87M
-49.11%75.07M
-43.23%80.00M
-34.66%88.39M
-38.31%91.09M
-10.22%147.53M
-20.71%140.92M
-27.79%135.28M
-23.94%147.66M
47.12%164.32M
47.71%177.74M
48.98%187.35M
49.84%194.14M
-45.11%111.69M
13.81%120.33M
19.92%125.76M
31.41%129.56M
Total equity
54.25%76.10M
63.58%92.25M
-74.36%16.63M
-54.42%34.05M
32.60%49.34M
198.99%56.39M
123.19%64.87M
119.48%74.71M
-7.39%37.21M
-68.79%18.86M
-65.56%29.06M
-66.96%34.04M
-42.32%40.18M
-33.71%60.43M
-16.82%84.38M
2.46%103.02M
18.42%69.66M
105.22%91.17M
58.94%101.44M
17.47%100.55M
Cash Flow Statement
Net operating income
37.35%-11.94M
39.78%-11.25M
-158.29%-15.27M
-36.33%-20.27M
-0.37%-19.05M
-121.81%-18.68M
74.40%-5.91M
29.64%-14.87M
39.67%-18.98M
61.44%-8.42M
-179.12%-23.09M
12.76%-21.13M
-8.98%-31.46M
7.76%-21.84M
222.09%29.19M
22.70%-24.22M
-142.41%-28.87M
-76.04%-23.68M
-7.57%-23.91M
-21.46%-31.34M
Net investment
63.69%-114.00K
-235.05%-325.00K
126.56%17.00K
57.14%-12.00K
-1107.69%-314.00K
-330.95%-97.00K
-100.85%-64.00K
97.35%-28.00K
96.39%-26.00K
106.65%42.00K
793.94%7.56M
-35.56%-1.06M
11.86%-721.00K
58.01%-632.00K
26.50%-1.09M
53.91%-779.00K
27.29%-818.00K
-37.32%-1.50M
-41.64%-1.48M
5.32%-1.69M
Net financing
-93.03%745.00K
1209.39%77.52M
-55.56%1.66M
654.99%5.30M
-73.35%10.69M
109.34%5.92M
11079.41%3.73M
-62.10%702.00K
5310.93%40.09M
--2.83M
81.11%-34.00K
-98.01%1.85M
-67.05%741.00K
-100.00%0.00
-101.51%-180.00K
587.66%92.92M
-93.87%2.25M
4131.31%8.38M
2139.85%11.92M
4641.05%13.51M

FAQs

What is the total revenue of Precision BioSciences Inc?

According to Precision BioSciences Inc's FY2025 earnings report, its total revenue reached 34.26M, with a year-on-year change of 68.70M.

What are the current assets of Precision BioSciences Inc?

According to Precision BioSciences Inc's FY2025 earnings report, its current assets were 118.74M, with a year-on-year change of 25.00.

What are the total assets of Precision BioSciences Inc?

According to Precision BioSciences Inc's FY2025 earnings report, its total assets of Precision BioSciences Inc were 154.42M, with a year-on-year change of 13.22.

What are the total liabilities of Precision BioSciences Inc?

According to Precision BioSciences Inc's FY2025 earnings report, its total liabilities of Precision BioSciences Inc were 62.17M, with a year-on-year change of -22.29.

What is the total equity of Precision BioSciences Inc?

According to Precision BioSciences Inc's FY2025 earnings report, its total equity of Precision BioSciences Inc was 92.25M, with a year-on-year change of 63.58.

What is the net operating income of Precision BioSciences Inc?

According to Precision BioSciences Inc's FY2025 earnings report, its net operating income of Precision BioSciences Inc was -52.15M, with a year-on-year change of -99.33.

What is the net investment of Precision BioSciences Inc?

According to Precision BioSciences Inc's FY2025 earnings report, its net investment of Precision BioSciences Inc was -634.00K, with a year-on-year change of -194.88.

What is the net financing of Precision BioSciences Inc?

According to Precision BioSciences Inc's FY2025 earnings report, its net financing of Precision BioSciences Inc was 95.16M, with a year-on-year change of 88.63.

What is the Earnings Per Share (EPS) of Precision BioSciences Inc?

According to Precision BioSciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.56, with a year-on-year change of -439.88.

What is the net income of Precision BioSciences Inc?

According to Precision BioSciences Inc's FY2025 earnings report, its net income was -45.72M, with a year-on-year change of -737.98.

What is the net margin of Precision BioSciences Inc?

According to Precision BioSciences Inc's FY2025 earnings report, its net profit margin was -136.03, with a year-on-year change of -1403.85.

What is the debt-to-asset ratio of Precision BioSciences Inc?

According to Precision BioSciences Inc's FY2025 earnings report, its debt-to-asset ratio was 14.51, with a year-on-year change of -11.35.

What is the Return on Equity (ROE) of Precision BioSciences Inc?

According to Precision BioSciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -62.71, with a year-on-year change of -429.25.

What is the Return on Assets (ROA) of Precision BioSciences Inc?

According to Precision BioSciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -32.06, with a year-on-year change of -762.33.

What is the operating profit of Precision BioSciences Inc?

According to Precision BioSciences Inc's FY2025 earnings report, its operating profit was -52.15M, with a year-on-year change of -99.33.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy